Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell

Cited by (1,000)

Items 301–400 of 1,000

  1. Cellular immunotherapy for medulloblastoma
    Michael Y. Schakelaar, Matthijs Monnikhof, Sandra Crnko, Emma W Pijnappel, Jan Meeldijk, Toine ten Broeke, Niels Bovenschen · 2022 · Neuro-Oncology
  2. Precision Medicine in Pediatric Neurooncology: A Review
    Aaron Y. Mochizuki, Isaura M. Frost, Melina B. Mastrodimos, Ashley Plant, Anthony Wang, Theodore Bruce Moore, Robert Michael Prins, Paul S. Weiss, Steven John Jonas · 2017 · ACS Chemical Neuroscience
  3. Molecular characterization of medulloblastomas with extensive nodularity (MBEN)
    Andrey Korshunov, Felix Sahm, Damian Stichel, Daniel Schrimpf, Marina Vladimirovna Ryzhova, Olga Zheludkova, Андрей Владимирович Голанов, Peter Lichter, David Jones, Andreas von Deimling et al. · 2018 · Acta Neuropathologica
  4. In silico analysis of long non-coding RNAs in medulloblastoma and its subgroups
    Piyush K. Joshi, George I. Jallo, Ranjan Joseph Perera · 2020 · Neurobiology of Disease
  5. MethylSPWNet and MethylCapsNet: Biologically Motivated Organization of DNAm Neural Networks, Inspired by Capsule Networks
    Joshua Levy, Youdinghuan Chen, Nasim Azizgolshani, Curtis Lee Petersen, Alexander Titus, Erika L. Moen, Louis Joseph Vaickus, Lucas A. Salas, Brock C. Christensen · 2021 · npj Systems Biology and Applications
  6. The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma
    Nemanja Sarić, Matthew P. Selby, Vijay Ramaswamy, Marcel Kool, Brigitta Stockinger, Christer Högstrand, Daniel Williamson, Silvia Marino, Michael D. Taylor, Steven C. Clifford et al. · 2020 · Scientific Reports
  7. Extracellular vesicle-associated miR-135b and -135a regulate stemness in Group 4 medulloblastoma cells by targeting angiomotin-like 2
    Seung Ah Choi, Eun Jung Koh, Ryong Nam Kim, Jung Woo Byun, Ji Hoon Phi, Jeyul Yang, Kyu‐Chang Wang, Ae Kyung Park, Do Won Hwang, Ji Yeoun Lee et al. · 2020 · Cancer Cell International
  8. Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
    Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini, Louis Chesler · 2021 · Frontiers in Oncology
  9. Childhood Medulloblastoma: An Overview
    Yujin Suk, William D. Gwynne, Ian Burns, Chitra Venugopal, Sheila Kumari Singh · 2022 · Methods in molecular biology
  10. TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
    Yufeng Zhang, Haiyan Yang, Liwen Wang, Huandi Zhou, Ge Zhang, Zhiqing Xiao, Xiaoying Xue · 2022 · Frontiers in Oncology
  11. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
    Matthew J. Kling, Varun Kesherwani, Nitish K. Mishra, Gracey R. Alexander, Erin M. McIntyre, Sutapa Ray, Kishore B. Challagundla, Shantaram S. Joshi, Donald W. Coulter, Nagendra K. Chaturvedi · 2022 · Journal of Experimental & Clinical Cancer Research
  12. Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
    Martin Mynarek, Denise Obrecht, Martin Sill, Dominik Sturm, Katja Kloth‐Stachnau, Florian Selt, Jonas Ecker, Katja von Hoff, Björn-Ole Juhnke, Tobias Goschzik et al. · 2022 · Acta Neuropathologica
  13. Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma
    M. Hope Robinson, Victor D Maximov, Shoeb B. Lallani, Hamza Farooq, Michael D. Taylor, Renee D Read, Anna Marie Kenney · 2019 · Scientific Reports
  14. Embryonal Tumors of the Central Nervous System
    Melissa M. Blessing, Sanda Alexandrescu · 2020 · Surgical pathology clinics
  15. Medulloblastoma: an Old Diagnosis with New Promises
    Luca Szalontay, Yasmin Khakoo · 2020 · Current Oncology Reports
  16. Long non-coding RNAs in brain tumors
    Keisuke Katsushima, George I. Jallo, Charles G. Eberhart, Ranjan Joseph Perera · 2021 · NAR Cancer
  17. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors
    Luca Bertero, Luca Mangherini, Alessia Andrea Ricci, Paola Cassoni, Felix Sahm · 2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  18. Oncogene aberrations drive medulloblastoma progression, not initiation
    Konstantin Okonechnikov, Piyush K. Joshi, Verena Körber, Anne Rademacher, Michele Bortolomeazzi, Jan‐Philipp Mallm, Jan Vaillant, Patricia Benites Goncalves da Silva, Britta Statz, Mari Sepp et al. · 2025 · Nature
  19. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment
    Anna Briel-Pump, Thomas Beez, Lara Ebbert, Marc Remke, Sandra Weinhold, Michael Sabel, Rüdiger V. Sorg · 2018 · Journal of Photochemistry and Photobiology B Biology
  20. Pediatric embryonal brain tumors in the molecular era
    Bryan K. Li, Salma A. Al-Karmi, Annie Huang, Éric Bouffet · 2020 · Expert Review of Molecular Diagnostics
  21. A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma
    Dong Wang, Angela M. Pierce, Bethany L. Veo, Susan P. Fosmire, Etienne P. Danis, Andrew M. Donson, Sujatha Venkataraman, Rajeev Vibhakar · 2021 · Cancers
  22. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker
    Nasim Azizgolshani, Curtis Lee Petersen, Youdinghuan Chen, Joshua Levy, Lucas A. Salas, Laurent Perreard, Lananh Nguyen, Brock C. Christensen · 2021 · Clinical Epigenetics
  23. Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin
    Satoshi Nakata, Junko Murai, Masayasu Okada, Haruhiko Takahashi, Tyler Findlay, Kristen J. Malebranche, Akhila Parthasarathy, Satoshi Miyashita, Ramil Gabdulkhaev, Ilan Benkimoun et al. · 2022 · Neuro-Oncology
  24. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging
    Franziska Linke, James E. C. Johnson, Stefanie Kern, Christopher Bennett, Anbarasu Lourdusamy, Daniel Lea, Steven C. Clifford, Catherine L.R. Merry, Snow Stolnik, Morgan R. Alexander et al. · 2023 · Acta Neuropathologica Communications
  25. The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies
    Hasan Slika, Paolo Alimonti, Divyaansh Raj, Chad A. Caraway, Safwan Alomari, Eric M. Jackson, Betty Tyler · 2023 · Cancers
  26. Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179
    Yuchen Li, Chaemin Lim, Taylor Dismuke, Daniel Shiloh Malawsky, Sho Oasa, Zara C. Bruce, Carolin Offenhäuser, Ulrich Baumgartner, Rochelle C. J. D’Souza, Stacey L. Edwards et al. · 2025 · Nature Communications
  27. Low Expression of miR-466f-3p Sustains Epithelial to Mesenchymal Transition in Sonic Hedgehog Medulloblastoma Stem Cells Through Vegfa-Nrp2 Signaling Pathway
    Zein Mersini Besharat, Claudia Sabato, Agnese Pò, Francesca Gianno, Luana Abballe, Maddalena Napolitano, Evelina Miele, Felice Giangaspero, Alessandra Vacca, Giuseppina Catanzaro et al. · 2018 · Frontiers in Pharmacology
  28. Molecular Genetics of Medulloblastoma in Children: Diagnostic, Therapeutic and Prognostic Implications
    Maher El Doussouki, Amar J. Gajjar, Omar Chamdine · 2019 · Future Neurology
  29. TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
    Malte Hellwig, Marlen C. Lauffer, Michael Ludwig Bockmayr, Michael Spohn, Daniel J. Merk, Luke Harrison, Julia Ahlfeld, Annabel Kitowski, Julia E. Neumann, Jasmin Ohli et al. · 2019 · Acta Neuropathologica
  30. Sonic hedgehog accelerates DNA replication to cause replication stress promoting cancer initiation in medulloblastoma
    Lukas Tamayo-Orrego, David Gallo, Frédéric Racicot, Amandine Bemmo, Sushmetha Mohan, Brandon Ho, Samer Salameh, T Hoang, Andrew P. Jackson, Grant W. Brown et al. · 2020 · Nature Cancer
  31. Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma
    Sihan Zhu, Fuhua Lin, Zhenghe Chen, Xiaobing Jiang, Ji Zhang, Qunying Yang, Yinsheng Chen, Jian Wang · 2020 · Frontiers in Genetics
  32. Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
    Marta Buzzetti, Sonia Morlando, Dimitrios Solomos, Ammara Mehmood, Alexander W. I. Cox, Mattia Chiesa, Yuri D’Alessandra, Michela Garofalo, Caroline H. Topham, Gianpiero Di Leva · 2021 · Scientific Reports
  33. Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23
    Peter Hau, Didier Frappaz, Elizabeth Jane Hovey, Martin G. McCabe, Kristian W. Pajtler, Benedikt Wiestler, Clemens Seidel, Stephanie Elisabeth Combs, Linda Dirven, Martin Klein et al. · 2021 · Cancers
  34. GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype
    Claudia Paret, Arsenij Ustjanzew, Sara Ersali, Larissa Seidmann, Richard Jennemann, Nicole Ziegler, Khalifa El Malki, Alexandra Russo, Arthur Wingerter, Franziska Ortmüller et al. · 2022 · Cancers
  35. Network medicine for patients' stratification: From single‐layer to multi‐omics
    Manuela Petti, Lorenzo Farina · 2023 · WIREs Mechanisms of Disease
  36. Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma
    Walderik W. Zomerman, Sabine L. A. Plasschaert, Siobhan Conroy, Frank J.G. Scherpen, Tiny Meeuwsen-de Boer, Harm Jan Lourens, Sergi Guerrero Llobet, Marlinde J. Smit, Lorian Slagter‐Menkema, Annika Seitz et al. · 2018 · Cell Reports
  37. Epigenetic cerebellar diseases
    Mercedes Serrano · 2018 · Handbook of clinical neurology
  38. BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language
    Charles Tapley Hoyt, Daniel Domingo‐Fernándéz, Martin Hofmann‐Apitius · 2018 · Database
  39. CITK Loss Inhibits Growth of Group 3 and Group 4 Medulloblastoma Cells and Sensitizes Them to DNA-Damaging Agents
    Gianmarco Pallavicini, Giorgia Iegiani, Gaia Elena Berto, Elisa Calamia, Edoardo Trevisiol, Andrea Veltri, Simona Allis, Ferdinando Di Cunto · 2020 · Cancers
  40. Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma
    Xiaohua Liu, Yu Zhang, Yalei Li, Juan Wang, Huaqian Ding, Wenjing Huang, Chunyong Ding, Hong‐Chun Liu, Wenfu Tan, Ao Zhang · 2020 · Acta Pharmaceutica Sinica B
  41. Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion
    Marc Thomas Schönholzer, Jessica Migliavacca, Elena Alvarez, Karthiga Santhana Kumar, Anuja Neve, Alexandre Gries, Min Ma, Michael Andreas Grotzer, Martin Baumgartner · 2020 · Neoplasia
  42. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors
    Bárbara Kunzler Souza, Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Andre Tesainer Brunetto, Rafael Roesler · 2021 · International Journal of Molecular Sciences
  43. Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study
    Christine Gaab, Jonas E Adolph, Stephan Tippelt, Ruth Mikasch, Denise Obrecht, Martin Mynarek, Stefan Rutkowski, Stefan Michael Pfister, Till Milde, Olaf Witt et al. · 2022 · Cancers
  44. Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models
    Jezabel Rodríguez‐Blanco, April Salvador, Robert K. Suter, Marzena Swiderska‐Syn, Isabel Palomo-Caturla, Valentin M. Kliebe, Pritika H. Shahani, Kendell D. Peterson, María Turos‐Cabal, Megan E. Vieira et al. · 2024 · Journal of Clinical Investigation
  45. Sterol regulation of developmental and oncogenic Hedgehog signaling
    Vikas Daggubati, David Ronan Raleigh, Navdar Sever · 2021 · Biochemical Pharmacology
  46. Immune cell landscape and immunotherapy of medulloblastoma
    Jin Zhang, Tianyou Wang · 2021 · Pediatric Investigation
  47. Noncanonical activation of GLI signaling in SOX2 + cells drives medulloblastoma relapse
    Marzena Swiderska‐Syn, Júlia Mir-Pedrol, Alexander R. Oles, Olga Schleuger, April Salvador, Sean M. Greiner, Cara Seward, Fan Yang, Benjamin R. Babcock, Chen Shen et al. · 2022 · Science Advances
  48. SADLN: Self-attention based deep learning network of integrating multi-omics data for cancer subtype recognition
    Qiuwen Sun, Lei Cheng, Ao Meng, Shuguang Ge, Jie Chen, Longzhen Zhang, Ping Gong · 2023 · Frontiers in Genetics
  49. Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
    Tuan Vo, Brad Balderson, Kahli Jones, Guiyan Ni, Joanna Crawford, Amanda Millar, Elissa Tolson, Matthew Singleton, Onkar Mulay, Shaun B. Walters et al. · 2023 · Genome Medicine
  50. The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma
    Piyush K. Joshi, Keisuke Katsushima, Rui Zhou, Avner Meoded, Stacie L. Stapleton, George I. Jallo, Eric H. Raabe, Charles G. Eberhart, Ranjan Joseph Perera · 2019 · Neuro-Oncology Advances
  51. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup
    Luciane Sussuchi da Silva, Bruna Minniti Mançano, Flávia Escremim de Paula, Mariana Bisarro dos Reis, Gisele Caravina de Almeida, Marcus De Medeiros Matsushita, Antônio Carlos, Adriane Feijó Evangelista, Fabiano Pinto Saggioro, Luciano Neder Serafini et al. · 2020 · Journal of Molecular Diagnostics
  52. Statins repress hedgehog signaling in medulloblastoma with no bone toxicities
    Qianhai Fan, Tingting Gong, Chaonan Zheng, Jessica M.Y. Ng, Jianquan Chen, Cynthia B. Myers, Harvey H. Hensley, Tom Curran, Zeng-jie Yang · 2021 · Oncogene
  53. Infant medulloblastoma — learning new lessons from old strata
    Marc Remke, Vijay Ramaswamy · 2018 · Nature Reviews Clinical Oncology
  54. Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma
    Amanda Thomaz, Kelly de Vargas Pinheiro, Bárbara Kunzler Souza, Lauro José Gregianin, Algemir Lunardi Brunetto, Andre Tessainer Brunetto, Caroline Brunetto de Farias, Mariane da Cunha Jaeger, Vijay Ramaswamy, Carolina Nör et al. · 2019 · Frontiers in Pharmacology
  55. REST promotes ETS1‐dependent vascular growth in medulloblastoma
    Shavali Shaik, Shinji Maegawa, Amanda R. Haltom, Feng Wang, Xue Xiao, Tara Dobson, Ajay Sharma, Yanwen Yang, Jyothishmathi Swaminathan, Vikas Kundra et al. · 2021 · Molecular Oncology
  56. Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
    Emma Martell, Helgi Kuzmychova, Esha Kaul, Harshal Senthil, Subir Roy Chowdhury, Ludivine Coudière Morrison, Agnes L. Fresnoza, Jamie L. Zagozewski, Chitra Venugopal, Christopher M. Anderson et al. · 2023 · Nature Communications
  57. Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment
    Lukas Tamayo-Orrego, Frédéric Charron · 2019 · F1000Research
  58. A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma
    Nagendra K. Chaturvedi, Matthew J. Kling, Connor N. Griggs, Varun Kesherwani, Mamta Shukla, Erin M. McIntyre, Sutapa Ray, Yutong Liu, Timothy R. McGuire, John Graham Sharp et al. · 2020 · Molecular Cancer Therapeutics
  59. 3D hydrogels reveal medulloblastoma subgroup differences and identify extracellular matrix subtypes that predict patient outcome
    Franziska Linke, Macha Aldighieri, Anbarasu Lourdusamy, Anna M. Grabowska, Snow Stolnik, Ian Derek Kerr, Catherine L.R. Merry, Beth Coyle · 2020 · The Journal of Pathology
  60. Adolescent and young adult neuro-oncology: a comprehensive review
    Kee Kiat Yeo, Darcy E. Burgers, Katelynn Brodigan, Karen M. Fasciano, A. Lindsay Frazier, Katherine E. Warren, David A. Reardon · 2021 · Neuro-Oncology Practice
  61. Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
    Victor Pereira, Jacob Torrejon-Diaz, Dulanjalee Kariyawasam, Pablo Berlanga, Léa Guerrini‐Rousseau, Olivier Ayrault, Pascale Varlet, Arnault Tauziède‐Espariat, Stéphanie Puget, Stéphanie Bolle et al. · 2021 · Neuro-Oncology Advances
  62. Genomics Paves the Way for Better Infant Medulloblastoma Therapy
    Giles W Robinson, Amar J. Gajjar · 2020 · Journal of Clinical Oncology
  63. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation
    Julian Bryan Iorgulescu, Jessica Van Ziffle, Meredith Stevers, James P. Grenert, Boris C. Bastian, Lukas Chávez, Damian Stichel, Ivo Buchhalter, David Samuel, Theodore P. Nicolaides et al. · 2018 · Acta Neuropathologica
  64. Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
    Jamie L. Zagozewski, Stephanie Borlase, Brent J. Guppy, Ludivine Coudière-Morrison, Ghazaleh M. Shahriary, Victor Dela Gordon, Lisa Liang, Stephen Cheng, Christopher J. Porter, Rhonda Kelley et al. · 2022 · Communications Biology
  65. Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics
    Jia‐Wei Lv, Chen‐Fei Wu, Junyan Li, Fo‐Ping Chen, Shiwei He, Qing‐Mei He, Guan‐Qun Zhou, Jun Ma, Ying Hao Sun, Denghui Wei et al. · 2022 · BMC Medicine
  66. Miat and interacting protein Metadherin maintain a stem-like niche to promote medulloblastoma tumorigenesis and treatment resistance
    Kai-Lin Peng, Harish N. Vasudevan, Dennis Timothy Lockney, Rachel Baum, Ronald C. Hendrickson, David Ronan Raleigh, Adam M. Schmitt · 2022 · Proceedings of the National Academy of Sciences
  67. Pediatric Brain Tumors in the Molecular Era: Updates for the Radiologist
    Jehan AlRayahi, Osamah Alwalid, Walid Mabrouk Mubarak, Ata Ur Rehman Maaz, William Mifsud · 2022 · Seminars in Roentgenology
  68. ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
    Oliver J. Mainwaring, Holger Weishaupt, Miao Zhao, Gabriela Rosén, Anna Borgenvik, Laura Breinschmid, Annemieke D. Verbaan, Stacey Richardson, Dean Thompson, Steven C. Clifford et al. · 2023 · Nature Communications
  69. Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types
    Matthias W Wagner, Pejman Jabehdar Maralani, Julie Bennett, Liana Figueiredo Nobre, Mary Jane Lim-Fat, Peter B. Dirks, Suzanne Laughlin, Uri Y. Tabori, Vijay Ramaswamy, Cynthia E Hawkins et al. · 2024 · Radiology
  70. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells
    Sophie J. Cowman, Yuen Ngan Fan, Barry L. Pizer, Violaine Sée · 2019 · BMC Cancer
  71. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time
    Somruetai Shuangshoti, Paveen Tadadontip, Piti Techavichit, Paul Scott Thorner, Shanop Shuangshoti, Chinachote Teerapakpinyo · 2019 · Applied immunohistochemistry & molecular morphology
  72. CENPE Inhibition Leads to Mitotic Catastrophe and DNA Damage in Medulloblastoma Cells
    Giorgia Iegiani, Marta Gai, Ferdinando Di Cunto, Gianmarco Pallavicini · 2021 · Cancers
  73. Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
    Marina Pagnuzzi‐Boncompagni, Vincent Picco, Valérie Vial, Vı́ctor Planas-Bielsa, Ashaina Vandenberghe, Thomas Daubon, Marie‐Alix Derieppe, Christopher Montemagno, Jérôme Durivault, Renaud Grépin et al. · 2021 · Cancers
  74. Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion
    Jessica Migliavacca, Buket Züllig, Charles Capdeville, Michael Andreas Grotzer, Martin Baumgartner · 2022 · Communications Biology
  75. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis
    Arnault Tauziède‐Espariat, Sophie Huybrechts, Émilie Indersie, Christelle Dufour, Stéphanie Puget, Anaïs Chivet, Alexandre Roux, Mélanie Pagès, Albane Gareton, Fabrice C Chrétien et al. · 2020 · The American Journal of Surgical Pathology
  76. Notch1 switches progenitor competence in inducing medulloblastoma
    Claudio Ballabio, Matteo Gianesello, Chiara Lago, Konstantin Okonechnikov, Marica Anderle, Giuseppe Aiello, Francesco Antonica, Tingting Zhang, Francesca Gianno, Felice Giangaspero et al. · 2021 · Science Advances
  77. DNA methylation alterations across time and space in paediatric brain tumours
    Anna Wenger, Sandra Ferreyra Vega, Elizabeth Schepke, Maja Löfgren, Thomas Olsson Bontell, Magnus Tisell, Daniel T. Nilsson, Teresia Kling, Helena Carén · 2022 · Acta Neuropathologica Communications
  78. Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment
    Julian S. Rechberger, Stephanie A. Toll, Wouter J. F. Vanbilloen, David J. Daniels, Soumen Khatua · 2023 · Diagnostics
  79. The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain Cancer
    Eduardo Mello Rodrigues, Allan Fernando Giovanini, Carmen Austrália Paredes Marcondes Ribas, Osvaldo Malafaia, Rafael Roesler, Gustavo Rassier Isolan · 2023 · Cancers
  80. Desmoplastic nodular medulloblastoma in young children: a management dilemma
    Mohamed Shebl Abdelbaki, Daniel R. Boué, Jonathan L. Finlay, Mark W. Kieran · 2017 · Neuro-Oncology
  81. Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups
    Charles T. Robbins, Mayassa J. Bou-Dargham, Kevin G. Sanchez, Matthew C. Rosen, Qing‐Xiang Amy Sang · 2018 · Journal of Cancer
  82. Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma
    Anuja Neve, Jessica Migliavacca, Charles Capdeville, Marc Thomas Schönholzer, Alexandre Gries, Min Ma, Karthiga Santhana Kumar, Michael Andreas Grotzer, Martin Baumgartner · 2019 · Cancers
  83. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis
    Carolini Kaid, Amanda F. Assoni, Marina Marçola, Patrícia Semedo, Raul Hernandes Bortolin, Valdemir Melechco Carvalho, Oswaldo Keith Okamoto · 2020 · Brain Research
  84. Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine
    Daniel C. Moreira, Sujatha Venkataraman, Apurva Subramanian, John A. DeSisto, Ilango Balakrishnan, Eric W. Prince, Angela M. Pierce, Andrea M. Griesinger, Adam Green, Charles G. Eberhardt et al. · 2020 · Journal of Neuro-Oncology
  85. Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study
    Xi Chen, Zhen Fan, Kay Ka‐Wai Li, Guoqing Wu, Zhong Hui Yang, Xin Gao, Yingchao Liu, Haibo Wu, Hong Chen, Qisheng Tang et al. · 2020 · Neuro-Oncology Advances
  86. YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA
    Andreas Kloetgen, Sujitha Duggimpudi, K Schuschel, Kebria Hezaveh, Daniel J. Picard, Heiner Schaal, Marc Remke, Jan‐Henning Klusmann, Arndt Borkhardt, Alice Carolyn McHardy et al. · 2020 · International Journal of Molecular Sciences
  87. VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
    Manon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, Rita A. Hanna, Jérôme Durivault, Magalie Leloire, Bastien Mejias, Marina Pagnuzzi, Amandine Morot, Fanny Burel‐Vandenbos et al. · 2020 · Communications Biology
  88. Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma
    Marina Danilenko, Steven C. Clifford, Ed C. Schwalbe · 2021 · Pharmacology & Therapeutics
  89. Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth
    Karthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, Levi Luca Kopp, Alexandre Gries, Yan Shen, Simon Jurt, Kerstin Moehle, Dominique Bruns, Michael Andreas Grotzer et al. · 2022 · Cellular Oncology
  90. Hedgehog pathway, cell cycle, and primary cilium
    Tenghan Zhuang · 2025 · Cell Death Discovery
  91. Current Strategies for Management of Medulloblastoma
    Michael D. Prados · 2023 · Diagnostics
  92. Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry
    Michael Woolman, Taira Kiyota, Siham Amara-Belgadi, Naohide Fujita, Alexa Fiorante, Vijay Ramaswamy, Craig E Daniels, James T. Rutka, Chris McIntosh, David G. Muñoz et al. · 2024 · Analytical Chemistry
  93. Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks
    Agnese Pò, Luana Abballe, Claudia Sabato, Francesca Gianno, Martina Chiacchiarini, Giuseppina Catanzaro, Enrico De Smaele, Felice Giangaspero, Elisabetta Ferretti, Evelina Miele et al. · 2018 · International Journal of Molecular Sciences
  94. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood
    Simone Minasi, Caterina Baldi, Torsten Pietsch, Vittoria Donofrio, Bianca Pollo, Manila Antonelli, Maura Massimino, Felice Giangaspero, Francesca Romana Buttarelli · 2019 · Journal of Neuro-Oncology
  95. Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma
    Kathleen M. Schieffer, Elizabeth Varga, Katherine E. Miller, Vibhuti Agarwal, Daniel C. Koboldt, Patrick Joseph Brennan, Benjamin Kelly, Ashita Dave‐Wala, Christopher R. Pierson, Jonathan L. Finlay et al. · 2019 · European Journal of Medical Genetics
  96. Medulloblastoma epigenetics and the path to clinical innovation
    Amanda R. Haltom, Stephanie A. Toll, Donghang Cheng, Shinji Maegawa, Vidya Gopalakrishnan, Soumen Khatua · 2020 · Journal of Neuro-Oncology
  97. Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile
    Daniel Shiloh Malawsky, Seth Weir, Jennifer Karin Ocasio, Benjamin R. Babcock, Taylor Dismuke, Abigail H. Cleveland, Andrew M. Donson, Rajeev Vibhakar, Kirk C. Wilhelmsen, Timothy R. Gershon · 2021 · Communications Biology
  98. Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
    Bo Qiu, Cassie Kline, Sabine Mueller · 2021 · Frontiers in Oncology
  99. Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
    Sara Badodi, Nicola Pomella, Yau Mun Lim, Sebastian Brandner, Gillian M. Morrison, Steven M. Pollard, Xinyu Zhang, Nicolae Radu Zabet, Silvia Marino · 2022 · Neuro-Oncology
  100. Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma
    Yi Zhu, Zhihui Liu, Yuduo Guo, Shenglun Li, Yanming Qu, Lin Dai, Yujia Chen, Weihai Ning, Hongwei Zhang, Lixin Ma · 2022 · Frontiers in Oncology